Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1083147.RAZYllq5TJoLiVJMG8oQeVU5LO46yoJ6RUvWHMslEapWg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1083147.RAZYllq5TJoLiVJMG8oQeVU5LO46yoJ6RUvWHMslEapWg130_assertion type Assertion NP1083147.RAZYllq5TJoLiVJMG8oQeVU5LO46yoJ6RUvWHMslEapWg130_head.
- NP1083147.RAZYllq5TJoLiVJMG8oQeVU5LO46yoJ6RUvWHMslEapWg130_assertion description "[In addition, collaborative studies of BMPR2 mutation carriers should enable identification of environmental modifiers, biomarkers for disease development and progression, and surrogate markers for efficacy end points in clinical drug development, thereby providing an invaluable resource for trials of PAH prevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1083147.RAZYllq5TJoLiVJMG8oQeVU5LO46yoJ6RUvWHMslEapWg130_provenance.
- NP1083147.RAZYllq5TJoLiVJMG8oQeVU5LO46yoJ6RUvWHMslEapWg130_assertion evidence source_evidence_literature NP1083147.RAZYllq5TJoLiVJMG8oQeVU5LO46yoJ6RUvWHMslEapWg130_provenance.
- NP1083147.RAZYllq5TJoLiVJMG8oQeVU5LO46yoJ6RUvWHMslEapWg130_assertion SIO_000772 23733703 NP1083147.RAZYllq5TJoLiVJMG8oQeVU5LO46yoJ6RUvWHMslEapWg130_provenance.
- NP1083147.RAZYllq5TJoLiVJMG8oQeVU5LO46yoJ6RUvWHMslEapWg130_assertion wasDerivedFrom befree-2016 NP1083147.RAZYllq5TJoLiVJMG8oQeVU5LO46yoJ6RUvWHMslEapWg130_provenance.
- NP1083147.RAZYllq5TJoLiVJMG8oQeVU5LO46yoJ6RUvWHMslEapWg130_assertion wasGeneratedBy ECO_0000203 NP1083147.RAZYllq5TJoLiVJMG8oQeVU5LO46yoJ6RUvWHMslEapWg130_provenance.